Targeted therapy for small cell lung cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 452-454, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-463666
ABSTRACT
Targeted agents for small cell lung cancer (SCLC)include inhibitors of angiogenesis,tyro-sine kinase inhibitors and signal transduction pathway inhibitors.Bevacizumab,a class of antiangiogenic agent, tends to have no effects on patients.The tyrosine kinase inhibitor,for example sunitinib,may be used as a monotherapy.Signaling inhibitors including Amuvatinib and LDE225 are undergoing phaseⅠand Ⅱ trials.Pri-mary data show that SCLC is not sensitive to targeted therapy,needing more selection,so further studies are requested.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS